Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus
Clinical trial NCT00518375 · COMPLETED
Trial details
- NCT number
- NCT00518375
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.